Mellanox Technologies (Nasdaq: MLNX ) is expected to report Q2 earnings on July 24. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Mellanox Technologies's revenues will drop -28.6% and EPS will shrink -80.8%.
The average estimate for revenue is $95.3 million. On the bottom line, the average EPS estimate is $0.19.
Last quarter, Mellanox Technologies booked revenue of $83.1 million. GAAP reported sales were 6.4% lower than the prior-year quarter's $88.7 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $0.10. GAAP EPS were -$0.20 for Q1 against $0.29 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 65.2%, 220 basis points worse than the prior-year quarter. Operating margin was -9.5%, much worse than the prior-year quarter. Net margin was -10.2%, much worse than the prior-year quarter.
The full year's average estimate for revenue is $416.8 million. The average EPS estimate is $1.30.
The stock has a two-star rating (out of five) at Motley Fool CAPS, with 188 members out of 211 rating the stock outperform, and 23 members rating it underperform. Among 55 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 46 give Mellanox Technologies a green thumbs-up, and nine give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Mellanox Technologies is hold, with an average price target of $58.00.
Is Mellanox Technologies the best semiconductor stock for you? You may be missing something obvious. Check out the semiconductor company that Motley Fool analysts expect to lead "The Next Trillion-dollar Revolution." Click here for instant access to this free report.
- Add Mellanox Technologies to My Watchlist.